We propose that the mechanism by which CALHM1 dysregulation may contribute to AD is unlikely related to Aβ production and cytotoxicity, and that a potential role of CALHM1 in neuronal excitability merits further investigation. The gene discussed is CALHM1; the disease is Alzheimer disease.